| Financial Year |
March 31 2023 |
| Monetary Funds |
695,327,394.25 |
| Held-for-trading Financial Assets |
215,000.00 |
| Notes Receivable |
81,617,903.02 |
| Accounts Receivable |
1,148,502,150.85 |
| Advances to Suppliers |
60,414,715.67 |
| Other Receivables |
470,893,868.09 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
891,396.23 |
| Dividend Receivable |
-- |
| Inventories |
614,234,882.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,386,927.00 |
| Other Current Assets |
175,510,404.65 |
| Total Current Assets |
7,342,323,711.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
200,000.00 |
| Long-term Equity Investment |
48,502,055.51 |
| Investment Properties |
147,197,464.01 |
| Fixed Assetes |
1,107,214,845.37 |
| Under-construction Projects |
366,392,606.45 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
158,422,065.68 |
| R&D expenses |
-- |
| Goodwill |
1,945,690.84 |
| Long-Term Deferred and Prepaid Expenses |
39,572,555.20 |
| Deferred Income Tax Assets |
255,364,211.43 |
| Other Non-Current Assets |
45,005,436.01 |
| Sub-Total of Non-Current Assets |
2,225,492,362.79 |
| Total Assets |
9,567,816,074.42 |
| Short-Term Loans |
2,093,380,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
258,445,000.00 |
| Accounts Payable |
1,928,631,157.52 |
| Accounts Received In Advance |
178,286.17 |
| Employee Compensation Payable |
41,497,422.28 |
| Taxes Payable |
27,969,326.87 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
263,553,457.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,558,094,338.22 |
| Other Current Liabilities |
752,719,425.29 |
| Sub-Total of Current Liabilities |
7,107,308,335.74 |
| Long-term Loans |
1,139,590,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
134,353,372.83 |
| Special Payable |
-- |
| Estimatied Liabilities |
68,544,638.29 |
| Deferred Income Tax Liabilities |
81,571,179.72 |
| Other Non-Current Liabilities |
38,383,500.00 |
| Sub-Total of Non-Current Liabilities |
1,472,076,761.18 |
| Total Liabilities |
8,579,385,096.92 |
| Paid-In Capital(Or Share Stock) |
1,441,914,930.00 |
| Capital Surplus |
402,602,641.88 |
| Surplus Reserve |
86,642,112.07 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,112,042,421.50 |
| Minority Stockholder's Interest |
175,972,512.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
812,458,464.90 |
| Owner's Equity（Stockholder's Equity） |
988,430,977.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,567,816,074.42 |
